Please enter the email address you used to register, then we will send you a link to choose a new password
Spin-Off Distribution is Conditional Upon the Closing of Neurotrope's Proposed Merger with Metuchen Pharmaceuticals NEW YO...
Neurotrope Inc (NASDAQ:NTRP) was trading 1.10% higher from the previous closing price. A Form 4 filing filed with the SEC on...
Neurotrope Inc (NASDAQ:NTRP) was trading 3.6% higher from the previous closing price. A Form 4 filing filed with the SEC on Mon...
A Form 4 filing filed with the SEC on Thursday, October 22 showed that Schechter Jonathan bought 2,012 shares of Neurotrope Inc...
Neurotrope Inc (NASDAQ:NTRP) was trading 2.1% higher from the previous closing price. A Form 4 filing filed with the SEC on Tue...
Neurotrope Inc (NASDAQ:NTRP) was trading 4.6% higher from the previous closing price. Silverman Joshua filed a Form 4 with the ...
Neurotrope, Inc. (NASDAQ:NTRP) ("Neurotrope" or the "Company") today announced that its wholly-owned subsidiary...
By Anita Dushyanth, PhD NASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer's disease